Woodford reveals his full portfolio

published 14 July 2014

Star fund manager Neil Woodford recently revealed the top ten holdings in the new Woodford Equity Income fund.

Now he's gone one step further and announced the holdings in full on his fund website. Woodford intends that this will be updated every month.

It will come as no surprise that large-cap pharmaceutical stocks are among the favourites. AstraZeneca and GSK are the top two holdings, at 8.3% and 7.1% of the fund respectively. Other big firms from the sector include Roche, Sanofi, Novartis, and Prothena which together make up 9.9% of the portfolio.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

As my colleague Ed Bowsher remarked earlier today, Woodford is a big fan of tobacco stocks (not a view that Ed shares).In fact, tobacco makes up over 18% of the portfolio.

He's also keen on government outsourcers, with G4S, Serco and Capita making up 4.96%, and on traditional utilities - Drax, SSE, and Centrica come in at 4.9% of the portfolio.

Further down the list come quite a few small-cap pharmaceutical and biotech stocks, including ReNeuron, Retroscreen Virology, e-Therapeutics, Oxford Pharmascience, and 4D Pharma.

Biotech is a hot topic at the moment, and my colleague Matthew Partridge recently picked a couple of interesting small-cap biotech stocks that are looking in to the new generation of antibiotics.

And earlier this year in MoneyWeek magazine, he looked at the opportunities available to investors in stem-cell research.If you're not already a subscriber, get your first four copies free here.

Here's the full list of the stocks in the Woodford Equity Income Fund.

Swipe to scroll horizontally

1	AstraZeneca	Healthcare	8.3%
2	GlaxoSmithKline	Healthcare	7.1%
3	British American Tobacco	Consumer goods	6.2%
4	BT	Telecommunications	6%
5	Imperial Tobacco	Consumer goods	5.3%
6	Roche	Healthcare	3.9%
7	Imperial Innovations	Financials	3.6%
8	Reynolds American	Consumer goods	3.6%
9	Rolls-Royce	Industrials	3.5%
10	Capita	Industrials	3.4%
11	Allied Minds	Financials	2.9%
12	BAe Systems	Industrials	2.9%
13	HSBC	Financials	2.8%
14	Sanofi	Healthcare	2.3%
15	Legal & General	Financials	2.1%
16	Novartis	Healthcare	2%
17	Centrica	Utilities	2%
18	AA	Consumer services	1.9%
19	SSE	Utilities	1.8%
20	Reckitt Benckiser	Consumer goods	1.8%
21	Philip Morris International	Consumer goods	1.8%
22	Prothena	Healthcare	1.7%
23	Next	Consumer services	1.7%
24	Altria	Consumer goods	1.3%
25	Smith & Nephew	Healthcare	1.3%
26	BTG	Healthcare	1.2%
27	Provident Financial	Financials	1.1%
28	Drax	Utilities	1.1%
29	Alkermes	Healthcare	1%
30	Gagfah	Financials	1%
31	G4S	Industrials	0.97%
32	RM2 International	Industrials	0.93%
33	Redde	Financials	0.90%
34	Utilitywise	Industrials	0.62%
35	Serco	Industrials	0.59%
36	Meggitt	Industrials	0.59%
37	Lancashire	Financials	0.58%
38	Velocys	Oil & gas	0.55%
39	e-Therapeutics	Healthcare	0.54%
40	Vernalis	Healthcare	0.49%
41	ReNeuron	Healthcare	0.48%
42	Cobham	Industrials	0.48%
43	Burford Capital	Financials	0.44%
44	Catlin	Financials	0.43%
45	Benchmark	Healthcare	0.43%
46	Amlin	Financials	0.43%
47	4D Pharma	Healthcare	0.43%
48	Oxford Pharmascience	Healthcare	0.35%
49	Revolymer	Basic materials	0.31%
50	Hiscox	Financials	0.31%
51	Beazley	Financials	0.29%
52	Gigaclear	Telecommunications	0.29%
53	Paypoint	Industrials	0.25%
54	Homeserve	Industrials	0.09%
55	Retroscreen Virology	Healthcare	0.09%
56	Xeros	Industrials	0.07%
57	NetScientific	Healthcare	0.05%
58	IP	Financials	0.04%
59	Circassia	Healthcare	0.03%
60	Stobart	Industrials	0.03%
61	Cranswick	Consumer goods	0.01%

Ben studied modern languages at London University's Queen Mary College. After dabbling unhappily in local government finance for a while, he went to work for The Scotsman newspaper in Edinburgh. The launch of the paper's website, scotsman.com, in the early years of the dotcom craze, saw Ben move online to manage the Business and Motors channels before becoming deputy editor with responsibility for all aspects of online production for The Scotsman, Scotland on Sunday and the Edinburgh Evening News websites, along with the papers' Edinburgh Festivals website.

Ben joined MoneyWeek as website editor in 2008, just as the Great Financial Crisis was brewing. He has written extensively for the website and magazine, with a particular emphasis on alternative finance and fintech, including blockchain and bitcoin.

As an early adopter of bitcoin, Ben bought when the price was under $200, but went on to spend it all on foolish fripperies.